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Metabolic Conversion of l- and 2-Nitronaphthalene to l- and 2-Naphthylamine in the Rat. 
JOHNSON, D. E., AND CORNISH, H. H. (1978). Toxicol. Appl. Pharmacol. 46, 549-553. l- and 
2-Naphthylamine (c[- and /.-naphthylamine) were isolated as urinary metabolites of l- and 2. 
nitronaphthalene, respectively, in the rat. Isolation and identification were accomplished using 
preparative thin-layer chromatography and gas-liquid chromatography/mass spectral analysis. 
The evidence that metabolism of nitronaphthalenes leads to formation of the corresponding 
amines, one of which @-naphthylamine) is a known carcinogen, suggests that human exposure 
to this nitro compound should be minimal. It also points out the important role of metabolic 
studies in the evaluation of potential chemical toxicity and suggests a critical reevaluation of 
compounds whose metabolism by known pathways could lead to the in vivo formation of 
carcinogenic compounds. 
Carcinogenic aromatic amines and nitro compounds are metabolized to “activated” 
intermediates generally believed to be responsible for producing tissue alterations 
(Miller and Miller, 1969; Endo ef al., 1971). N-Oxidation of l- and 2-naphthylamine 
and nitroreduction of l- and 2-nitronaphthalene may lead to identical N-oxy 
intermediates (Fig. l), which have been shown to be carcinogenic and/or mutagenic in 
several in vitro and in vivo studies (Bonser et al., 1963; Boyland et al., 1963; Perez and 
Radomski, 1965; Bell et al., 1968; Radomski et al., 1971; Ong and deserres, 1972; 
Radomski et al., 1973). 
In this report we give details on the isolation and identification of l- and 2- 
naphthylamine isolated from the urine of rats injected with the corresponding 
nitronaphthalene (Johnson and Cornish, 1976). This gives new evidence that the 
common intermediate hypothesis, shown in Fig. 1, is real, and thus the potential 
carcinogenicity of 2-nitronaphthalene must now be considered. 
As shown in Fig. 1 considerable interest centered on studies of the metabolism of l- 
and 2-naphthylamine because of the demonstrated carcinogenicity of 2-naphthylamine. 
Since nitroreduction of the nitronaphthalenes may lead to the same intermediates as the 
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N-oxidation of the naphthylamines, it was of interest to determine initially if this overall 
pathway was functional in the whole animal. Poirer and Weisburger (1974) had 
demonstrated, in vitro, that the reduction of aromatic nitro compounds to the 
corresponding amines could indeed occur. Thus, the purpose of the present study was to 
determine whether conversion of nitronaphthalenes to naphthylamines occurred in the 
rat. This, of itself, would not establish that common intermediates existed in the 
metabolism of these two series of compounds but would suggest the need for 
reexamination of the metabolic fate of the nitronaphthalenes, as well as renewed study 
of other compounds whose metabolites could give rise to carcinogenic compounds. 
Ila JIIa 
Ib IIb IIIb Eb 
FIG. 1. Proposed common intermediates in the metabolism of the nitronaphthalenes and naphthylamines. 
Ia, 1-nitronaphthalene; IIa, 1-nitrosonaphthalene; IIIa, N-hydroxy-1-naphthylamine; IVa, l-naphthyl- 
amine; Ib, 2-nitronaphthalene; IIb, 2-nitrosonaphthalene; IIIb, N-hydroxy-2-naphthylamine; IVb, 
2-naphthylamine. 
Pathways known to exist Reference 
In vivo 
IVa -+ (IIIa)’ + IIa Radomski and Brill(l970) 
IV\, -+ (IIIb)b + IIb Radomski and Brill(l970) 
Ib -, IIb + (IIIb)b Radomski et al. (1973) 
In vitro 
IVa + (IIIa)b + IIa Brill and Radomski (197 1) 
IVb -, (IIIb)b + IIb Brill and Radomski (197 1) 
Ia + IVa Poirier and Weisburger (1974) 
Ib --t IVb Poirier and Weisburger (1974) 
Ia + IIIa Sternson (1975) 
a Measured after conversion to IIa. 
b Measured after conversion to IIb. 
METHODS 
l- and 2-Nitronaphthalene (l-NN, 2-NN) were purchased from Aldrich Chemical 
Company, Inc., recrystallized prior to use, and shown to be amine free on the basis of 
thin-layer chromatography (tic) and gas-liquid chromatography (glc). l- 
Naphthylamine (l-NA) and 2-naphthylamine (2-NA) standards were purchased from 
Aldrich Chemical Company, Inc. and Sigma Chemical Company, respectively. l-NN, 
2-NN, and l-NA were checked for purity and shown to be single components on the 
basis of melting points and tic in five diierent solvent systems. In additon, l-NA and 2- 
NA were analyzed by a combination of glc and mass spectrometry and found to be 
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pure by these criteria. Solutions for injection were made in peanut oil with a small 
amount of ether for solubilization; dosages were 100 mg/kg body wt. 
Single intraperitoneal injections of l- or 2-nitronaphthalene were given to adult male 
Sprague-Dawley rats and subsequent 24 hr urine samples collected on a freezing unit. 
The urine samples were thawed, pooled, diluted fourfold with distilled water, and 
extracted three times with ether. The ether layers and interfacial emulsion were 
removed, placed in glass-stoppered centrifuge tubes, frozen in an acetone-dry ice 
mixture, and centrifuged immediately upon thawing. The ether layer was removed, dried 
over anhydrous sodium sulfate, filtered, and concentrated under a stream of nitrogen. 
The residue was taken up in anhydrous methanol and applied to activated preparative 
tic plates.4 
The plates were developed in benzene : 95% ethanol (19 : 1) for 45 min and dried, and 
the l- or 2-naphthylamine band (uv absorbing) was removed and eluted with ethyl 
acetate in a micro-descending chromatography column. The extracts were concentrated 
under nitrogen and the residues taken up in a small amount of methanol for glc/mass 
spectral analysis. The glc/mass spectral analyses were performed on a AEI MS 30 
interfaced to a PYE Model 104 glc unit and a digital pdp 8/m data output system 
incorporating a Tektronix 4010-l visual display unit.5 A 5-ft column of 3% OV-17 on 
gas chrom Q was used for the GLC separation. (Conditions: glc, 180°C isothermal; 
MS, 25 eV, 50 mV.) 
RESULTS 
The glc retention times and mass fragmentation spectra of 2-naphthylamine isolated 
as a metabolite of 2-nitronaphthalene and the 2-naphthylamine standard were identical. 
The base peak was the molecular ion (m/e 143) and the major fragmentation was a loss 
of HCN, (M-27) or (M-l-27), which is analogous to other aromatic amines and 
identical to published 2-naphthylamine spectra (Registry of Mass Spectral Data, 1974). 
The glc retention times and mass spectral data for 1-naphthylamine isolated as a 
metabolite of 1-nitronaphthalene and the I-naphthylamine standard were also identical. 
The base peak was the molecular ion (m/e 143), and the loss of HCN from l- 
+ 
naphthylamine also resulted in the (M-27) and (M-l-27) fragments. 
DISCUSSION 
The present study has demonstrated that l- and 2-nitronaphthalene are converted to 
l- and 2-naphthylamine, respectively, in the rat (Johnson and Cornish, 1976). This 
supports the in vitro work of Poirer and Weisburger (1974). Although no evidence has 
been presented in this paper on the nature of possible intermediates in the pathway from 
the nitro compound to the corresponding amine, the summary (Fig. 1) of available in 
vivo and in vitro data suggests the likelihood of several intermediates in common with 
4 Prekotes (silica gel GF), 250 pm, 20 x 20 cm with fluorescent indicator, Applied Science 
Laboratories, Inc. 
5 Mass spectrometer Model 30, Assoc. Electronics Industry, Manchester, England; Model 104 gas- 
liquid chromatography unit, P. G. PYE Ltd., Cambridge, England; Model PDP 8/m data output system, 
Dee Digital Equip. Co.; Model 4010-l visual display unit, Tektronic Corp., Portland, Oregon. 
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those involved in the metabolism of l- and 2-naphthyiamine. Since 2-naphthylamine is a 
known bladder carcinogen the implications of a common metabolic pathway with 2- 
nitronaphthalene need to be considered. These studies suggest the need for further 
evaluation of the nitronaphthalenes and the need for, more detailed metabolic studies of 
related nitro compounds and other chemicals whose metabolic pathways may involve 
the formation of known or suspected carcinogens. 
Moore et al. (1977) have recently referred to an unpublished report indicating that 2- 
nitronaphthalene is metabolized to 2-naphthylamine @-naphthylamine) in the dog; 
hence evidence of this metabolic pathway in at least two species now exists. In 
agreement with their recommendation, it is apparent that the nitronaphthalenes and 
biological samples from animals treated with the nitronaphthalenes should be handled in 
a manner consistent with the safety precautions and laboratory practice used for 
handling potentially dangerous compounds. Further, it would seem prudent that 
laboratory and industrial personnel should minimize their exposure to the nitro- 
naphthalenes in the course of research or manufacturing activities. 
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